Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial
Marius Trøseid(Oslo University Hospital), Alpha Diallo, Joe Eustace(University College Cork), Isabel Püntmann(DAK-Gesundheit (Germany)), Anders Benjamin Kildal(University Hospital of North Norway), Fridtjof Lund‐Johansen(Oslo University Hospital), Sotirios Tsiodras(National and Kapodistrian University of Athens), Matthias Briel(University Hospital of Basel), Zoltán Péterfi(University of Pecs), Elin Westerheim(Oslo University Hospital), A.M. Baldé(Gamal Abdel Nasser University of Conakry), Michael Joannidis(Innsbruck Medical University), Mary‐Anne Trabaud(Hospices Civils de Lyon), José Ramón Arribas(Hospital Universitario La Paz), Maude Bouscambert‐Duchamp(Hospices Civils de Lyon), Jannicke Horjen Møller(Stavanger University Hospital), Lucie de Gastines(Inserm), Monika Halánová(University of Pavol Jozef Šafárik), Vida Terzić(Inserm), Lars Heggelund(Drammen Hospital), Kristian Tonby(Oslo University Hospital), Asgeir Johannessen(University of Oslo), Fulvia Mazzaferri(University of Verona), Maya Hites(Université Libre de Bruxelles), Beatriz Díaz‐Pollán(Hospital Universitario La Paz), Florence Ader(Université Claude Bernard Lyon 1), Olav Dalgård(University of Oslo), Jesús Rodríguez‐Baño(Hospital Universitario Virgen Macarena), Lydie Béniguel(Inserm), Cecilie Delphin Amdal(Oslo University Hospital), Karine Lacombe(Inserm), Michael Rezek(University Hospital Brno), Kateřina Nezvalová‐Henriksen(Oslo University Hospital), Serge Rodrigues Serge Rodrigues(Université Sorbonne Nouvelle), Jean‐Christophe Richard(Hôpital de la Croix-Rousse), Anders Tveita, Aleksander Rygh Holten(Oslo University Hospital), Tuva B. Dahl(Oslo University Hospital), Serhat Ünal(Hacettepe University), Thale D.J.H. Patrick-Brown(Oslo University Hospital), Lambert Assoumou(Inserm), Burç Aydın(Oslo University Hospital), Marta del Álamo, Martin Schlegel(University Children's Hospital Tübingen), Joy Mootien(Centre Hospitalier de Mulhouse), Jean Reuter(Inserm), Alexandre Gaudet, Julien Poissy(Université de Lille), Victoria Charlotte Simensen(Norwegian Institute of Public Health)
Cited by 1
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Prone Positioning in Severe Acute Respiratory Distress Syndrome
|New England Journal of Medicine|2013|4.1k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k